Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Regenerx Biopharmaceuticals Inc (RGN)  
$0.01 0.00 (0.00%) as of 4:30 Tue 10/17


Download
   
Exchange: American Stock Exchange
Security Type: Common
Shares Out: 106,883,000
Market Cap: 1.04(M)
Last Volume: 9,926 Avg Vol: 80,069
52 Week Range: $0.009725 - $0.07205
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    AMEX COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   RegeneRX Biopharmaceuticals is a biopharmaceutical company focused on the development of a therapeutic peptide, Thymosin beta 4 (Tss4), for tissue and organ protection, repair, and regeneration. Co. has formulated Tss4 into three product candidates in clinical development: RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease or other pathology; RGN-352, an injectable formulation to treat cardiovascular diseases, central and peripheral nervous system diseases, and other medical indications that may be treated by systemic administration; and RGN-137, a topical gel for dermal wounds and reduction of scar tissue.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 37
  Page 1 of 2  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Goldstein Allan L Director   •       •      –    2021-12-08 4 GD $0.00 $0 D/D 130,000 1,507,793     -
   Finkelstein J J President and CEO   •       •      –    2021-06-30 4 B $0.20 $15,000 D/D 75,000 1,712,991 2.81 -40%     
   Goldstein Allan L Director   –       •      –    2021-06-30 4 B $0.20 $25,000 D/D 125,000 1,637,793 2.39 -40%     
   Cavazza Paolo 10% Owner   –       –       •   2021-06-30 4 B $0.20 $300,000 I/I 1,500,000 1,500,000 1.5 -40%     
   Goldstein Allan L Director   –       •      –    2019-06-12 4 GD $0.00 $0 D/D 228,000 1,712,793     -
   Goldstein Allan L Director   –       •      –    2019-01-06 4 OE $0.06 $12,535 D/D 208,912 1,940,793     -
   Mcnay Joseph C Director   –       •      –    2019-01-06 4 OE $0.06 $31,337 D/D 522,280 6,524,122     -
   Cavazza Preta Martina 10% Owner   –       –       •   2018-09-27 4 OE $0.06 $188,021 D/D 3,133,681 34,989,080     -
   Elsey R Don Director   –       •      –    2018-09-11 4 OE $0.06 $6,267 D/D 104,456 104,456     -
   Mcnay Joseph C Director   –       •      –    2018-09-11 4 OE $0.06 $125,347 D/D 2,089,120 6,001,842     -
   Goldstein Allan L Director   –       •      –    2018-09-11 4 OE $0.06 $13,788 D/D 229,803 1,731,881     -
   Finkelstein J J President and CEO   •       •      –    2018-07-05 4 OE $0.06 $6,267 D/D 104,456 1,637,991     -
   Mcnay Joseph C Director   –       •      –    2018-07-05 4 OE $0.06 $62,674 D/D 1,044,560 3,912,722     -
   Goldstein Allan L Director   –       •      –    2018-07-05 4 OE $0.06 $12,535 D/D 208,912 1,502,078     -
   Mcnay Joseph C Director   –       •      –    2018-03-29 4 OE $0.06 $62,674 D/D 1,044,560 2,868,162     -
   Goldstein Allan L Director   –       •      –    2018-03-29 4 OE $0.06 $31,337 D/D 522,280 1,293,166     -
   Cavazza Preta Martina 10% Owner   –       –       •   2018-03-13 4 B $0.23 $4,124,745 D/D 17,933,673 31,855,399 2.45     -
   Sinaf S.a. 10% Owner   –       –       •   2018-03-13 4 S $0.23 $2,664,503 D/D (11,584,795) 0     -
   Goldstein Allan L Director   –       •      –    2018-01-30 4 GD $0.00 $0 D/D 250,000 770,886     -
   Mcnay Joseph C Director   –       •      –    2017-10-19 4 OE $0.15 $10,000 D/D 66,667 1,823,602     -
   Mcnay Joseph C Director   –       •      –    2017-10-19 4 OE $0.15 $62,674 D/D 417,824 1,756,935     -
   Finkelstein J J President and CEO   •       •      –    2017-10-19 4 OE $0.15 $3,000 D/D 20,000 1,533,535     -
   Finkelstein J J President and CEO   •       •      –    2017-10-19 4 OE $0.15 $18,802 D/D 125,347 1,513,535     -
   Goldstein Allan L Director   –       •      –    2017-10-19 4 OE $0.15 $7,000 D/D 46,666 1,020,886     -
   Goldstein Allan L Director   –       •      –    2017-10-19 4 OE $0.15 $43,872 D/D 292,477 974,220     -
  37 Records found
  1  2   
  Page 1 of 2
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us